Actinium Pharma: Falls on deeply discounted stock offering

Actinium Pharmaceuticals

22/04/2020 11:13

** Shares of drug developer  ATNM.A  fall 28% to 17 cents-
among most heavily traded stocks and second biggest pct loser
across U.S. exchanges
    ** Co on Tuesday priced 183,333,334 shares of its common
stock at 15 cents/shr, representing a discount of 36.4% to
ATNM's last close  urn:newsml:reuters.com:*:nPnMXVyDa
    ** ATNM intends to use gross proceeds of ~$27.5 mln to
complete a late-stage trial for its cancer therapy and file
marketing application for the same
    ** Co had 164.7 mln shares outstanding as of April 21-
Refinitiv IBES
    ** Stock gained 3.5% YTD as of last close

 (Reporting by Trisha Roy in Bengaluru)
 ((Trisha.Roy@thomsonreuters.com; within U.S. +1 646 223 8780,
outside U.S. +91 80 6182 3635;))